Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with ( 11 C)McN 5652

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with... Justine M. Kent +1-212-5435437 JMK14@columbia.edu Jeremy D. Coplan Ilise Lombardo Dah-Ren Hwang Yiyun Huang Osama Mawlawi Ronald L. Van Heertum Mark Slifstein Anissa Abi-Dargham Jack M. Gorman Marc Laruelle New York State Psychiatric Institute, Unit 41, 1051 Riverside Drive, New York, NY 10032, USA Department of Psychiatry, Columbia University College of Physicians & Surgeons, New York, N.Y., USA Department of Radiology, Columbia University College of Physicians & Surgeons, New York, N.Y., USA State University of New York (Downstate), New York, N.Y., USA Abstract Rationale. Although selective serotonin reuptake inhibitors (SSRIs) are widely used in the treatment of anxiety and depressive disorders, the occupancy of the serotonin reuptake transporter (SERT) achieved in humans at typical clinical doses by these agents remains poorly characterized. Objective. The purpose of this study was to determine the occupancy of the SERT achieved in vivo by the SSRI paroxetine in social phobia patients at typical antianxiety doses. Methods. Measures of SERT availability were obtained with positron emission tomography and the SERT radiotracer ( 11 C)(+)-McN 5652 in five patients with social phobia before and during treatment with paroxetine at usual therapeutic doses (20–40 mg per day). Results. Occupancy of the SERT by paroxetine was high in all subjects and in all regions measured after 3–6 months of continuous treatment. Conclusions. The results of this study in an anxiety disorder sample are consistent with previously reported results in a depressed sample and suggest that paroxetine at therapeutic doses achieves very high occupancy levels of the SERT. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with ( 11 C)McN 5652

Loading next page...
 
/lp/springer-journals/occupancy-of-brain-serotonin-transporters-during-treatment-with-V60Dk0KT88
Publisher
Springer Journals
Copyright
Copyright © 2002 by Springer-Verlag
Subject
Legacy
ISSN
0033-3158
eISSN
1432-2072
DOI
10.1007/s00213-002-1218-8
pmid
12457263
Publisher site
See Article on Publisher Site

Abstract

Justine M. Kent +1-212-5435437 JMK14@columbia.edu Jeremy D. Coplan Ilise Lombardo Dah-Ren Hwang Yiyun Huang Osama Mawlawi Ronald L. Van Heertum Mark Slifstein Anissa Abi-Dargham Jack M. Gorman Marc Laruelle New York State Psychiatric Institute, Unit 41, 1051 Riverside Drive, New York, NY 10032, USA Department of Psychiatry, Columbia University College of Physicians & Surgeons, New York, N.Y., USA Department of Radiology, Columbia University College of Physicians & Surgeons, New York, N.Y., USA State University of New York (Downstate), New York, N.Y., USA Abstract Rationale. Although selective serotonin reuptake inhibitors (SSRIs) are widely used in the treatment of anxiety and depressive disorders, the occupancy of the serotonin reuptake transporter (SERT) achieved in humans at typical clinical doses by these agents remains poorly characterized. Objective. The purpose of this study was to determine the occupancy of the SERT achieved in vivo by the SSRI paroxetine in social phobia patients at typical antianxiety doses. Methods. Measures of SERT availability were obtained with positron emission tomography and the SERT radiotracer ( 11 C)(+)-McN 5652 in five patients with social phobia before and during treatment with paroxetine at usual therapeutic doses (20–40 mg per day). Results. Occupancy of the SERT by paroxetine was high in all subjects and in all regions measured after 3–6 months of continuous treatment. Conclusions. The results of this study in an anxiety disorder sample are consistent with previously reported results in a depressed sample and suggest that paroxetine at therapeutic doses achieves very high occupancy levels of the SERT.

Journal

PsychopharmacologySpringer Journals

Published: Dec 1, 2002

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off